Jennison Associates LLC Buys 21,089 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Jennison Associates LLC increased its position in Option Care Health, Inc. (NASDAQ:OPCH) by 4.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 493,363 shares of the company’s stock after buying an additional 21,089 shares during the period. Jennison Associates LLC owned 0.29% of Option Care Health worth $11,446,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. UMB Bank n.a. grew its stake in Option Care Health by 937.5% in the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after acquiring an additional 750 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. grew its position in Option Care Health by 3,362.8% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after purchasing an additional 1,446 shares during the period. International Assets Investment Management LLC increased its stake in Option Care Health by 3,029.7% during the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after purchasing an additional 2,757 shares in the last quarter. Finally, Quarry LP raised its holdings in Option Care Health by 327.7% during the third quarter. Quarry LP now owns 3,430 shares of the company’s stock worth $107,000 after buying an additional 2,628 shares during the last quarter. 98.05% of the stock is owned by institutional investors.

Option Care Health Stock Performance

Shares of OPCH stock opened at $31.32 on Thursday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The firm has a market cap of $5.33 billion, a price-to-earnings ratio of 26.32, a P/E/G ratio of 2.19 and a beta of 1.35. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $34.63. The firm’s 50-day simple moving average is $25.60 and its two-hundred day simple moving average is $27.88.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the stock. JPMorgan Chase & Co. lifted their price objective on shares of Option Care Health from $38.00 to $40.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Truist Financial decreased their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a report on Friday, November 1st. Barrington Research increased their price objective on Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 14th. JMP Securities reaffirmed a “market outperform” rating and set a $30.00 target price (down previously from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Finally, UBS Group initiated coverage on Option Care Health in a research report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target for the company. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $32.25.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the firm’s stock in a transaction that occurred on Friday, November 8th. The stock was bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the acquisition, the director now owns 326,334 shares in the company, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.64% of the stock is currently owned by insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.